Document:

exv10w1

Exhibit 10.1

[Cash America International, Inc. Letterhead]

January 16, 2009

Mr. John A. McDorman III

7624 Meadowhaven Drive

Dallas, Texas 75254

     Re: Separation of Employment

Dear John:

     This letter agreement and release of claims (the “Agreement”) sets forth the terms and
conditions governing the termination of your employment relationship with Cash America Management
L.P., and any relationship with Cash America International, Inc., and their affiliates and
subsidiaries (collectively, the “Company”). Additionally, it is agreed that this Agreement sets
forth the entire agreement between you and the Company (the “Parties”) and its predecessors,
directors, officers, employees, agents and representatives relating to the separation of your
employment.

     Except as expressly provided herein, this Agreement is not intended to alter the form or
timing of any severance pay or benefits provided to you under any prior arrangement, including, but
not limited to, the Cash America International, Inc. Severance Pay Plan for Executives (the
“Severance Plan”) but is intended to provide for certain additional payments and benefits described
herein. Your separation from the Company under this Agreement is an Eligible Termination for
purposes of Section 2(c) of the Severance Plan.

     Your separation from service is effective January 16, 2009 (the “Severance Date”). In
consideration of your separation from service, you and the Company agree to the following:

	(1)	 	If you agree to and accept the terms contained in this Agreement, you must sign the Agreement
in the space provided below and return one fully executed original of this Agreement to the
Company by February 9, 2009, which date is more than 21 days after the date that this
Agreement is being delivered to you. If you elect to sign this Agreement and return an
original of it to the Company, you will have seven (7) days after you deliver the original of
the Agreement to the Company during which you may revoke your acceptance. If you choose to
revoke your acceptance, you must notify the Company in writing, and the Company must receive
the notification by the expiration of this seven-day period. If you do not sign this
Agreement within the time period required by law, or if you revoke your acceptance during the
revocation period described above, this
Agreement will be of no further force or effect, and you will not be entitled to any of the
payments or benefits described herein.

Confidential

1

 

	(2)	 	Your separation from all offices and positions held by you in the Company will be effective
as of January 16, 2009. Your Executive Change-In-Control and Severance Agreement shall also
automatically terminate as of January 16, 2009.
	 
	(3)	 	If you sign the Agreement in the manner described in paragraph (1) above and you do not
thereafter revoke your acceptance, the Company will pay to you a single lump-sum payment in
the total gross amount of $248,421.14 (less all applicable deductions), between August
21st and September 18th 2009.
	 
	(4)	 	If you sign this Agreement in the manner described in paragraph (1) above and you do not
thereafter revoke your acceptance, the Company will pay to you severance pay in the amount of
$318,701.28 (“Salary Continuation Pay”), less applicable withholdings required by law.
The Salary Continuation Pay is for the period between the Severance Date and December 31,
2009. These payments will commence on the January 23, 2009 pay date (subject to the
expiration of the revocation period of the Agreement, as described in Section 4 of the
Severance Plan), and will end on the Company’s regularly scheduled payday that includes
payment of wages for the pay period that includes December 31, 2009. During this period, the
Salary Continuation Pay will be paid in substantially equal installments in accordance with
the Company’s normal payroll practices and policies (as provided in Section 3(a)(ii)(B) of the
Severance Plan).
	 
	(5)	 	If you sign the Agreement in the manner described in paragraph (1) above and you do not
thereafter revoke your acceptance, the Company will pay to you in a single lump sum an amount
equal to $25,569.23, which reflects the value of 160 hours of vacation. This lump-sum
amount will be paid to you between February 6th and February 20th 2009.
	 
	(6)	 	If you sign the Agreement in the manner described in paragraph (1) above and you do not
thereafter revoke your acceptance, the Company will provide group welfare benefits, including,
but not limited to, group medical, dental and vision benefits under the Company’s group health
plan(s) as provided in Section 3(a)(iii) of the Severance Plan.
	 
	(7)	 	This Agreement provides for any and all payments to you for any reason associated with your
employment with the Company up to and including January 16, 2009. You will not be entitled to
receive any amounts under any other plan, program or agreement with the Company (including,
without limitation, incentive pay under the Cash America 2009 Short Term Incentive Plan or any
other incentive plan, Restricted Stock Units (including the 2008 special award) or any other
awards under the Cash America International, Inc. 2004 Long-Term Incentive Plan, or any
agreement or arrangement providing benefits or
payments in the event of a change in corporate control); and all other benefits and
perquisites that you are currently receiving will cease on January 16, 2009. The foregoing
will not, however, affect any vested benefits (except for any portion of the 

Confidential

2

 

	 	 	Performance Award granted under your Cash America International, Inc. 2008 Long Term Incentive Plan
Award Agreement that could vest under the Rule of 65, which portion of the award you hereby
agree is forfeited) to which you are entitled after separation under the terms of any
Company benefit or compensation plan in which you are a participant (including, without
limitation, the Company’s Supplemental Executive Retirement Plan (“SERP”)). The foregoing
will also not affect your receipt of any 2008 Short Term Incentive or any 2008 contribution
to the SERP for which you were eligible as of December 31, 2008 should such discretionary
incentive be granted by the Company’s Board of Directors.

	(8)	 	You agree not to say, write, do, authorize or otherwise create or publish anything that will
in any way disparage the Company or any of its employees. You also agree not to interfere
with the management of the Company through any contact with shareholders, directors,
employees, vendors and others, and not to make any public or private statements or comments
that may have the effect of disrupting operations of the Company in any way.
	 
	(9)	 	The terms and conditions of this Agreement are to be held in strict confidence by you and
characterized as “confidential information.” The Parties further agree that the terms and
conditions of this Agreement will not be further disclosed to any other person or entity (with
the exception of the Parties’ attorneys, accountants and your current spouse, provided such
individuals agree to maintain the confidentiality requirements of this paragraph (9)), unless
such party is required to do so by a valid order of a court of competent jurisdiction, or as
required by law. Any disclosure of “confidential information” to any third-party will be
construed as a material breach of this Agreement.
	 
	(10)	 	It is further agreed that you will return to the Company, on or before January 31, 2009, all
Company property currently in your possession, including without limitation, computers, PDAs,
keys, credit cards, cellular phones, pagers and all papers, lists and other materials that
relate to, or involve, the business of the Company and that are in your possession or control.
	 
	(11)	 	You further agree to give up any claim to reinstatement with the Company. You also agree not
to apply for re-employment with the Company or any related Company during the Severance
Period. Following the expiration of the Severance Period, you may apply for employment and be
evaluated along with all other qualified applicants in accordance with the Company’s hiring
policies and procedures.
	 
	(12)	 	You acknowledge that during the term of your employment you have been privy to confidential
and proprietary information of the Company. You agree to not disclose to any third party the
trade secrets, proprietary information, marketing strategies, business 

Confidential

3

 

	 	 	strategies, business
plans, pricing data, legal analyses, financial information, insurance information, customer
lists, customer information, creditor files, processes, policies, procedures, research, lists,
methodologies, specifications, software, software code, computer systems, software and
hardware architecture and specifications, customer information systems, point of sale systems,
management information systems, software design and development plans and materials,
intellectual property, contracts, business records, technical expertise and know-how, and
other confidential and proprietary information and trade secrets of the Company (collectively,
the “Property”), which were provided to you by the Company and are confidential and
proprietary property of the Company. You further agree not to use any Property to your
personal benefit or the benefit of any third party. You also agree to return to the Company
by your Severance Date all such Property which is tangible. Notwithstanding the foregoing,
the Property protected hereunder does not include any data or information that has been
disclosed to the public (except where such public disclosure has been made by you without
authorization), that has been independently developed and disclosed by others, or that
otherwise enters the public domain through lawful means. The restrictions in this provision
are in addition to, and not in lieu of, any rights or remedies the Company may have available
pursuant to the laws of the State of Texas to prevent the disclosure of trade secrets and
proprietary information. Your obligations under the nondisclosure provisions hereof (i) will
apply to confidential information that does not constitute trade secrets for a period of 36
months after your Severance Date, and (ii) will apply to trade secrets until such Property no
longer constitutes trade secrets.

	(13)	 	You agree that, for 12 months after your Severance Date, you will not, directly or
indirectly, solicit, recruit or induce any employee, officer, agent or independent contractor
of the Company to terminate such party’s engagement with the Company so as to work for any
person or business which competes with the Company for talent; provided, the restrictions set
forth in this provision will only apply to employees, officers, agents or independent
contractors with whom you had business contact during the 12-month period prior to your
Severance Date.
	 
	(14)	 	You agree that, for 12 months after your Severance Date, you will not, on your own behalf or
on behalf of any other person or entity (including without limitation any entity that you may
form, join, consult with, provide services or assistance to or on behalf of, or otherwise
become affiliated with), compete with the Company anywhere within the Territory by providing
management or consulting services similar to those you provided to the Company with respect to
any products or services similar to those offered (or under development) by the Company on
your Severance Date (“Company Products and
Services”). For purposes of this Agreement, the term “Territory” will mean any territory in
which the Company offers Company Products or Services on the Severance Date, plus any
additional territory into which the Company has actively and directly sought to 

Confidential

4

 

	 	 	expand during the 12-month period preceding the Severance Date in which you were involved.

	(15)	 	You agree that, for 12 months after your Severance Date, you will not, on your own behalf or
on behalf of any other person or entity, solicit, initiate contact, call upon, initiate
communication with or attempt to initiate communication with any customer or client of the
Company or any representative of any customer or client of the Company, with a view to
providing Company Products and Services to such clients or customers; provided, the
restrictions set forth in this provision will apply only to customers or clients of the
Company with whom you had contact within the 12-month period prior to your Severance Date.
	 
	(16)	 	You acknowledge and agree that the provisions hereof relating to confidential and proprietary
information, nonsolicitation of employees and agents, noncompetition, and nonsolicitation of
customers and clients (collectively, the “Covenants”) are reasonable and valid and do not
impose limitations greater than those that are necessary to protect the business interests and
confidential information of the Company. You expressly agree and consent that, and represent
and warrant to the Company that, the Covenants will not prevent or unreasonably restrict or
interfere with your ability to make a fair living. You agree that the invalidity or
unenforceability of any one or more of the Covenants, or any part thereof, will not affect the
validity or enforceability of the other Covenants, all of which are inserted conditionally on
their being valid in law. In case any one or more of the Covenants contained in this
Agreement shall be held to be invalid, illegal or unenforceable in any respect for any reason,
such invalidity, illegality or unenforceability shall not affect any other provision hereof,
and this Agreement shall be construed as if such invalid, illegal or unenforceable Covenant
had never been contained herein. You also agree that in the event any court of appropriate
jurisdiction should determine that any portion or provision of any Covenant is invalid,
unenforceable or excessively restrictive, you and the Company will request such court to
rewrite such Covenant in order to make such Covenant legal, enforceable and acceptable to such
court to the maximum extent permissible under applicable law. You agree that the Covenants
contained in this Agreement are severable and divisible; that none of such Covenants depends
on any other Covenant for its enforceability; that such Covenants constitute enforceable
obligations between you and the Company; that each such Covenant will be construed as an
agreement independent of any other Covenant of this Agreement; and that the existence of any
claim or cause of action by one party to this Agreement against the other party to this
Agreement, whether predicated on this Agreement or otherwise, will not constitute a defense to
the enforcement by any party to this Agreement of any such Covenant.

Confidential

5

 

	 	 	You agree that any remedy at law for any breach of the Covenants will be inadequate and that
the Company will be entitled to apply for injunctive relief in addition to any other remedy
the Company might have under this Agreement or applicable law.
	 
	 	 	You acknowledge that, in addition to seeking injunctive relief, the Company may bring a
cause of action against you for any and all losses, liabilities, damages, deficiencies,
costs (including, without limitation, court costs), and expenses (including, without
limitation, reasonable attorneys’ fees), incurred by the Company and arising out of or due
to any breach of any of the Covenants. In addition, you agree that either party may bring
an action against the other for breach of any other provision of this Agreement.
	 
	(17)	 	This Agreement is intended to comply with the requirements of Section 409A of the Internal
Revenue Code of 1986, as amended, and guidance issued thereunder (“Section 409A”) and shall be
construed accordingly. Any payments or distributions payable to you under this Agreement upon
your “separation from service” (as defined for purposes of Section 409A) of amounts classified
as “nonqualified deferred compensation” for purposes of Section 409A, and not exempt from
Section 409A, shall in no event be made or commence until six (6) months after such separation
from service. Each payment under this Agreement (whether of cash, property or benefits) shall
be treated as a separate payment for purposes of Section 409A. With respect to payments or
benefits provided under this Agreement that are reimbursements or in-kind payments that are
not exempt from Section 409A, the amount of such payment(s) or benefit(s) during any calendar
year shall not affect payment(s) or benefit(s) provided in any other calendar year, and the
right to any payment(s) or benefit(s) shall not be subject to liquidation or exchange for
another benefit. Any reimbursements under this Agreement shall be paid as soon as practicable
but no later than 90 days after you submit evidence of such expenses to the Company (which
payment date shall in no event be later than the last day of the calendar year following the
calendar year in which the expense was incurred).

     In consideration of the above, including the mutual agreements of the parties hereto and the
payments to be made to you hereunder, the receipt and sufficiency of which are hereby acknowledged
and confessed by you, you (on behalf of yourself and your successors and assigns) voluntarily and
knowingly, fully, completely, and forever release the Company and its officers, directors,
employees, stockholders, and legal successors and assigns of the Company (collectively, “Released
Parties”) from all claims, charges, actions and causes of action, whether now known or unknown,
which you now have, or at any other time had, or shall or may have against those Released Parties
based upon or arising out of any matter, cause, fact, thing, act or omission whatsoever occurring
at any time up to and including the date you sign this Agreement , including, but not limited to,
any claims for claims based upon or arising under: express or implied contract; wages or benefits
owed; covenants of fair dealing and good faith; interference
with contract; option grants; wrongful discharge or termination; employment discrimination of

Confidential

6

 

any type; the Texas Commission on Human Rights Act (“TCHRA”), and any similar statute in other
states; the Texas Payday Act, the Texas Labor Code, and any similar statute in other states; any
claim of employment discrimination based on exercising rights under worker’s compensation laws;
Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. § 2000e, et seq. (prohibiting
discrimination on account of race, sex, national origin or religion); the Age Discrimination in
Employment Act of 1967, as amended, 29 U.S.C. §§ 621, et seq. (prohibiting discrimination on
account of age) (ADEA); the Civil Rights Act of 1991; the Civil Rights Acts of 1866 and 1871, 42
U.S.C. §§ 1981; Employee Retirement Income Security Act of 1974, as amended, 29 U.S.C. § 1001, et
seq. (ERISA); the Americans with Disabilities Act of 1990, as amended, 42 U.S.C. §§ 12101-12213
(ADA); the Family and Medical Leave Act, 29 U.S.C. § 2601, et seq. (FMLA); the Fair Labor Standards
Act, 29 U.S.C. § 201, et seq. (FLSA); the Workers’ Adjustment and Retraining Notification Act
(“WARN”); any and all state and federal statutes which prohibit discrimination or retaliation in
employment based on any protected status (including, without limitation, national origin, race,
sex, sexual orientation, disability, workers’ compensation status, or other protected category) and
amendments to these statutes; the common law, negligence, gross negligence or any other tort claim,
including but not limited to, intentional infliction of emotional distress, negligent infliction of
emotional distress, negligence, defamation, assault, battery, invasion of privacy, false
imprisonment, breach of contract, interference with a contract, interference with contractual
relations, civil conspiracy, duress, promissory or equitable estoppel, defamation, fraud,
misrepresentation, wrongful termination, violation of public policy, retaliation, personal injury,
breach of fiduciary duty, loss of consortium, bad faith, and any federal, state or local laws,
statutes, regulations, ordinances, or other similar provisions. You understand that you are not
releasing any claims that arise after the date you sign this Agreement.

     You understand that following the seven-day revocation period, this release will be final and
binding. You promise that you on behalf of yourself and any representative, and any person whose
claims derive from yours, will not pursue any claim that you have settled by this release or file
any lawsuit or other legal proceeding to assert any such claims and you understand and agree that
you will not be entitled hereafter to pursue any claims arising out of any alleged violation of
your rights while employed by the Company, including, but not limited to, claims for back pay,
losses or other damages. If you break any of the promises set forth in the previous sentence, you
agree to pay all of the Company’s costs and expenses (including reasonable attorneys’ fees) related
to the defense of any claims except for claims arising under the Older Workers Benefit Protection
Act (OWBPA) and the ADEA. Although you are releasing claims that you may have under the OWBPA and
ADEA, you understand that you may challenge the knowing and voluntary nature of this release before
a court, the Equal Employment Opportunity Commission (EEOC), or any other federal, state or local
agency charged with the enforcement of any employment laws. You also understand that nothing in
this release prevents you from filing a charge or complaint with or from participating in an
investigation or proceeding conducted by the EEOC or any other federal, state or local agency
charged with the enforcement of any

Confidential

7

 

employment laws. You understand, however, that if you pursue a claim against the Company
under the OWBPA and/or the ADEA to challenge the validity of this release and prevail on the merits
of an ADEA claim, a court has the discretion to determine whether the Company is entitled to
restitution, recoupment, or set off (hereinafter “reduction”) against a monetary award obtained by
you in the court proceeding. A reduction never can exceed the amount you recover, or the
consideration you received for signing this release, whichever is less. Furthermore, you give up
your right to individual damages or remedies in connection with any administrative or judicial
proceeding with respect to your employment or termination of employment with the Company. You also
recognize that the Company may be entitled to recover costs and attorneys fees incurred by the
Company as specifically authorized under applicable law.

     You on behalf of yourself and any representative, and any person whose claims derive from
yours, promises that no lawsuit or claim has been or will be filed based on any claims released by
this Agreement. If such a lawsuit or claim has been or is filed, you agree to withdraw or dismiss
such lawsuit or claims upon signing this Agreement; otherwise, you agree to pay all attorneys’ fees
and court costs incurred by the Company or any other released party in defending against the
lawsuit, claim or charge, along with other appropriate damages.

     This Agreement is not an admission on the Company’s part of any liability whatsoever or that
it in any way has acted improperly or unlawfully. The Company specifically denies any liability or
improper or unlawful conduct.

     If any claims are made by or against the Company which arise out of or relate to your
employment with the Company, you agree that you will cooperate fully in the investigation and
defense of such claims, including but not limited to preparation for and providing truthful
testimony.

     This Agreement is intended by you and the Company to be a legally valid and binding agreement.
If any provision of this Agreement if found to be illegal, invalid or unenforceable, such term or
provision shall be severable, and this Agreement shall be construed and enforced as if such
illegal, invalid or unenforceable provision were never a part hereof; the remaining provisions
hereof shall remain in full force and effect and shall not be affected by the illegal, invalid or
unenforceable provision or by its severance; and in lieu of such illegal, invalid or unenforceable
provision, there shall be added as part of this Agreement, a provision as similar in its terms to
such illegal, invalid or unenforceable provision, as may be possible and be legal, valid or
enforceable.

Confidential

8

 

     This Agreement shall be construed and enforced in accordance with the laws of the State of
Texas, United States, and venue for any action brought in connection with this Agreement shall lie
in Tarrant County, Texas, U.S.A.

     The Company wishes you success in your future endeavors.

	 	 	 	 	 
	 	Very truly yours,

Cash America Management L.P.

By its General Partner, Cash America Holding, Inc.

 	 
	 	By:  	/s/ Dan Feehan
 	 
	 	 	Title:      CEO 	 
	 	 	 	 

Confidential

9

 

	 	 	 	 	 

     I have read the foregoing Agreement, agree to its terms, and acknowledge receipt of a copy of
same, and the sufficiency of the payments recited in it. I understand and acknowledge that I
should seek counsel from an attorney with regard to all aspects of this Agreement (including, but
not limited to the release contained in it) and that I have had a sufficient opportunity to do so.
I hereby voluntarily enter into this Agreement effective as of January 16, 2009, with full
knowledge of its meaning and significance. I acknowledge and warrant that I have been given a
period of at least 21 days within which to consider this Agreement prior to executing it, if I so
desire. This Agreement may be revoked by me for a period of 7 days following its execution. To be
effective, the revocation must be in writing and received by the Company by the expiration of this
seven-day period.

	 	 	 	 	 
	 	 	 
	/s/ John McDorman
 	 	 
	Signature 	 	 
	 
	1/19/09
 	 	 
	Date 	 	 
	 

Confidential

10exv10w3

Exhibit 10.3

CONFIDENTIAL TREATMENT REQUESTED BY CASH AMERICA INTERNATIONAL, INC. 

CONFIDENTIAL PORTIONS OF THIS
DOCUMENT HAVE BEEN REDACTED AND FILED 
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.

CASH AMERICA INTERNATIONAL, INC.

2009 LONG TERM INCENTIVE PLAN AWARD AGREEMENT

     This Long Term Incentive Plan Award Agreement (the
“Agreement”) is entered into as of the ___ day of __________, _____, by and between CASH AMERICA INTERNATIONAL, INC. (the “Company”)
and ____________________. (“Employee”).

WITNESSETH:

     WHEREAS, the Company has adopted the Cash America International, Inc. 2004 Long-Term Incentive
Plan (the “Plan”), which is administered by the Management Development and Compensation
Committee of the Company’s Board of Directors (the “Committee”); and

     WHEREAS, the Committee has granted to Employee an award (the “Award”) of Restricted
Stock Units (known under the Plan as a “Stock Unit Award”) to encourage Employee’s
continued loyalty and diligence that consists of (a) a Stock Unit Award that shall vest under the
terms of the Plan over a four-year period (the “Base Award”), and (b) an additional Stock
Unit Award that shall vest, subject to the satisfaction of certain conditions specified in this
Agreement and Exhibit “A” to this Agreement, on January 1, 2012 (the “Performance Award”);

     WHEREAS, the Restricted Stock Units (“RSUs”) represent the unfunded and unsecured
promise of the Company to issue to Employee an equivalent number of shares of the common stock of
the Company or its successors (“Common Stock”) at a future date, subject to the terms of
this Agreement.

     NOW, THEREFORE, for and in consideration of the mutual promises herein contained, and for
other good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties agree as follows:

     1. Award.

          (a) General. Subject to the restrictions and other conditions set forth herein and in
Exhibit “A” to this Agreement, the Company hereby grants to Employee the following Award:

               (i) a Base Award of __________ RSUs; and

               (ii) a Performance Award of __________ RSUs. The Performance Award is designated as a
Qualified Performance-Based Award as defined in Section 2 of the Plan.

          (b) Grant Date. The Award was awarded to Employee on January 28, 2009 (the “Grant Date”).

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

 

 

     2. Vesting.

          (a) Base Award Vesting. The Base Award shall vest as follows: Substantially equal
25% increments of the RSUs shall vest on each of the following dates as long as Employee remains
continuously employed by the Company or its subsidiaries or other affiliates through such dates:
February 27, 2010; January 31, 2011; January 31, 2012, and January 31, 2013. Any RSUs that are
part of the Base Award and have not vested shall remain subject to forfeiture under Section 3 of
this Agreement.

          (b) Performance Award Vesting. Subject to the terms and conditions specified on
Exhibit “A,” the portion of the Performance Award payable hereunder, if any, shall vest on January
1, 2012 (“Performance Award Vesting Date”), as long as Employee remains continuously
employed by the Company or its subsidiaries or other affiliates through said date, subject to
receiving Committee Certification (as defined on Exhibit “A”). In addition, if at any time before
the Performance Award Vesting Date Employee’s age plus tenure with the Company equals at least 65
years (as further described in Section 3(b) of this Agreement), then, subject to the terms and
conditions specified on Exhibit “A,” the portion of the Performance Award payable hereunder, if
any, shall vest subject (i) to receiving Committee Certification, and (ii) to the proration rules
set forth in Section 3(b) of this Agreement.

     3. Treatment of Award Upon Termination of Employment or Failure to Vest.

          (a) Base Award Forfeiture. Upon Employee’s termination of employment with the Company
and all of its subsidiaries and affiliates for any reason (including death), any portion of the
Base Award that has not yet vested as provided in Section 2(a) of this Agreement shall be
immediately forfeited, and Employee shall forfeit any and all rights in or to such unvested portion
of the Base Award.

          (b) Performance Award Proration and Forfeiture with Rule of 65. If Employee’s
employment with the Company and all of its subsidiaries and affiliates terminates for any reason
(including death) before the Performance Award Vesting Date and Employee’s age plus tenure with the
Company as of Employee’s termination date equals 65 years or more:

	 	i.	 	Subject to the terms and conditions of Exhibit “A,”
Employee shall be entitled to a prorated portion of any Performance Award
(A) that receives the Committee Certification, and (B) that would have
otherwise vested and been payable pursuant to this Agreement if Employee
had remained employed by the Company through the Performance Award Vesting
Date. Such prorated portion shall be determined by multiplying the amount
of the Performance Award that would have been payable to Employee, had
Employee remained employed by the Company through the Performance Award
Vesting Date, by a fraction the numerator of which is equal to the number
of whole calendar months following the Grant Date that Employee was
actively employed by the Company, and the denominator of which is equal to
35;
	 
	 	ii.	 	The prorated portion of the vested Performance Award
payable under this Section 3(b) shall be calculated as of the Performance
Award Vesting Date, and shall be paid at the time specified under Section 4
of this Agreement; and

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

2

 

	 	iii.	 	Except for any prorated portion of the Performance
Award that is determined in accordance with Section 3(b)(i) above and is
certified by the Committee in accordance with the terms of Exhibit “A,”
Employee shall forfeit any and all rights in or to the remaining unvested
portion of the Performance Award.

          (c) Performance Award Forfeiture without Rule of 65. If Employee’s employment with
the Company and all of its subsidiaries and affiliates terminates for any reason (including death)
before the Performance Award Vesting Date, and Employee’s age plus tenure with the Company as of
Employee’s termination date equals less than 65 years, then Employee shall forfeit all rights in or
to any portion of the Performance Award.

          (d) Performance Award Forfeiture — General. Any portion of the Performance Award that
does not vest on or before the Performance Award Vesting Date as described hereinabove shall be
forfeited, and Employee shall forfeit any and all rights in or to such unvested portion of the
Performance Award.

          (e) Tenure with the Company. For purposes of Sections 3(b) and 3(c) of this
Agreement, Employee’s “tenure with the Company” shall be the number of whole years that Employee
had been employed by the Company and all of its subsidiaries and affiliates on the most recent
anniversary of the commencement of Employee’s employment.

     4. Payment of Awards.

          (a) General.

	 	i.	 	Except as provided in Section 4(b)(i) below, (A) as
each 25%-portion of the Base Award vests, the Company shall instruct its
transfer agent to issue a stock certificate evidencing the conversion of
such vested RSUs into whole vested shares of Common Stock in the name of
Employee (or if Employee has died, in the name of Employee’s designated
beneficiary or, if no beneficiary has been designated, Employee’s estate
(“Beneficiary”)) within a reasonable time after the vesting date of such
25%-portion of the Base Award, but (B) in no event will the Common Stock
relating to the then-vesting portion of the Base Award be transferred to
Employee later than December 31 of the calendar year in which the vesting
date for the then-vesting portion of the Base Award occurs.
	 
	 	ii.	 	If any portion of the Performance Award vests and is
certified by the Committee in accordance with the terms of Exhibit “A,”
then, except as provided in Section 4(b)(ii) below, (A) the Company shall
instruct its transfer agent to issue a stock certificate evidencing the
conversion of all vested Performance Award RSUs certified by the Committee
that have not been forfeited under Section 3 of this Agreement into whole
vested shares of Common Stock in the name of Employee (or if Employee has
died, in the name of Employee’s Beneficiary) within a reasonable time after
the Committee Certification Date (as defined in Exhibit “A”), but (B) in no
event will the Common Stock relating to the vested portion of the
Performance

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

3

 

	 	 	 	Award, as certified by the Committee, be transferred to Employee later
than March 15, 2013.
	 
	 	iii.	 	The Company shall not be required to deliver any
fractional shares of Common Stock under the Base Award or the Performance
Award. Any fractional shares shall be rounded up to the next whole share.

          (b) Deferred Delivery.

	 	i.	 	Employee may elect to defer the timing of the payment
of the vested portions of the Base Award granted under this Agreement until
(A) the date Employee has a separation from service (within the meaning of
Internal Revenue Code (“Code”) §409A and the applicable guidance
issued thereunder, as reflected in the Plan) (“Separation from
Service”) or (B) the earlier of Employee’s Separation from Service and
January 31, 2013. For all portions of the Base Award granted under this
Agreement, such deferral election must be made no later than February 27,
2009.
	 
	 	ii.	 	Employee may elect to defer but not accelerate the
timing of the payment of the portion of the Performance Award granted under
this Agreement that vests and is certified by the Committee in accordance
with this Agreement, if any, until the later of January 31, 2013, or the
date Employee has a Separation from Service. Such election must be made by
the earlier of June 30, 2011, or the date Employee has a Separation from
Service.
	 
	 	iii.	 	To the extent required under Code §409A and applicable
guidance issued thereunder (“Code §409A”), if Employee is a
specified employee (within the meaning of Code §409A) at the time Employee
has a Separation from Service and has elected to defer receipt of his Base
Award and/or Performance Award, the shares of Common Stock transferable on
a deferred basis as a result of Employee’s Separation from Service for any
reason other than Employee’s death shall not be issued before the date that
is six months after Employee’s Separation from Service or such earlier time
as may be permitted under Code §409A. In the event of Employee’s death
after he has elected to defer receipt of his Base Award and/or Performance
Award, the shares of Common Stock relating to any and all outstanding RSUs
that have not been forfeited under Section 3 of this Agreement will be
issued in the name of Employee’s Beneficiary, as follows: (A) for the Base
Award, within 90 days after Employee’s death, and (B) for any vested
Performance Award certified by the Committee, by the latest to occur of (a)
March 15, 2013, (b) December 31 of the year in which his death occurs, or
(c) within 21/2 months after his date of death.

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

4

 

     5. Change in Control.

          (a) Vesting and Payment. In the event of a Change in Control (as defined below) while
Employee is still employed by the Company or its subsidiaries or other affiliates, vesting of the
entire Award (both the Base Award and the Performance Award) shall automatically accelerate and
become 100% vested as of the date the Change in Control occurs as long as Employee has remained
continuously employed through such date. In such event, the shares of Common Stock evidencing
vested RSUs shall be delivered to Employee in a lump sum within 60 days following the date of the
Change in Control, notwithstanding any election made under Section 4(b) of this Agreement. A
“Change in Control” shall mean an event that is a change in the ownership of the Company, a
change in the effective control of the Company or a change in the ownership of a substantial
portion of the assets of the Company, all as defined in Code §409A, except that 35% shall be
substituted for 30% in applying Treasury Regulations Section 1.409A-3(i)(5)(vi) and 50% shall be
substituted for 40% in applying Treasury Regulations Section 1.409A-3(i)(5)(vii). Notwithstanding
the above, a “Change in Control” shall not include any event that is not treated under Code
§409A as a change in control event with respect to Employee.

          (b) Substitution. Notwithstanding anything set forth herein to the contrary, upon a
Change in Control, the Committee, in its sole discretion, may, in lieu of issuing Common Stock,
provide Employee with an equivalent amount payable in the form of cash.

     6. Agreement of Employee. Employee acknowledges that certain restrictions under state
or federal securities laws may apply with respect to the shares of Common Stock to be issued
pursuant to the Award. Specifically, Employee acknowledges that, to the extent Employee is an
“affiliate” of the Company (as that term is defined by the Securities Act of 1933), the shares of
Common Stock to be issued as a result of the Award are subject to certain trading restrictions
under applicable securities laws (including particularly the Securities and Exchange Commission’s
Rule 144). Employee hereby agrees to execute such documents and take such actions as the Company
may reasonably require with respect to state and federal securities laws and any restrictions on
the resale of such shares which may pertain under such laws. Notwithstanding anything herein to
the contrary and only to the extent permitted under Code §409A, a payment may be delayed to the
extent the Company reasonably anticipates that making the payment will violate federal securities
laws or other applicable laws.

     7. Withholding. Upon the issuance of shares to Employee pursuant to this Agreement,
Employee shall pay an amount equal to the amount of all applicable federal, state and local
employment taxes which the Company is required to withhold at any time. Such payment may be made
in cash, by withholding from Employee’s normal pay or short term incentive pay (if any), or, with
respect to the issuance of shares to Employee pursuant to this Agreement, by delivery of shares of
Common Stock (including shares issuable under this Agreement) in accordance with Section 14(a) of
the Plan and the terms of Code §409A.

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

5

 

     8. Adjustment of Awards.

          (a) If there is an increase or decrease in the number of issued and outstanding shares of
Common Stock through the payment of a stock dividend or resulting from a stock split-up, a
recapitalization, or a combination or exchange of shares of Common Stock, then the number of
outstanding RSUs hereunder shall be adjusted so that the proportion of such Award to the Company’s
total issued and outstanding shares of Common stock remains the same as existed immediately prior
to such event.

          (b) Except as provided in Section 8(a) of this Agreement, no adjustment in the number of
shares of Common Stock subject to any outstanding portion of the RSUs shall be made upon the
issuance by the Company of shares of any class of its capital stock or securities convertible into
shares of any class of capital stock, either in connection with a direct sale or upon the exercise
of rights or warrants to subscribe therefor, or upon conversion of shares or obligations of the
Company’s convertible into such shares or other securities.

          (c) Upon the occurrence of events affecting Common Stock other than those specified in
Sections 8(a) and 8(b) of this Agreement, the Committee may make such other adjustments to awards
as are permitted under Section 5(c) of the Plan. This section shall not be construed as limiting
any other rights the Committee may have under the terms of the Plan.

     9. Plan Provisions.

          In addition to the terms and conditions set forth herein, the Award is subject to and governed
by the terms and conditions set forth in the Plan, as may be amended from time to time, which are
hereby incorporated by reference. Any terms used herein with an initial capital letter shall have
the same meaning as provided in the Plan, unless otherwise specified herein. In the event of any
conflict between the provisions of the Agreement and the Plan, the Plan shall control.

     10. Miscellaneous.

          (a) Limitation of Rights. The granting of the Award and the execution of the
Agreement shall not give Employee any rights to (1) similar grants in future years, (2) any right
to be retained in the employ or service of the Company or any of its affiliates or subsidiaries, or
(3) interfere in any way with the right of the Company or its affiliates or subsidiaries to
terminate Employee’s employment or services at any time.

          (b) Claims Procedure. Any dispute or claim for benefits by any person under this
Agreement shall be determined by the Committee in accordance with the claims procedures under the
Cash America International, Inc. Nonqualified Savings Plan.

          (c) Shareholder Rights. Neither Employee nor Employee’s Beneficiary shall have any of
the rights of a shareholder with respect to any shares of Common Stock issuable upon vesting of any
Stock Unit Award until (i) such Award is vested and, if applicable with respect to the Performance
Award, certified by the Committee, and (ii) such shares have been delivered and issued to Employee
or Employee’s Beneficiary pursuant to Section 4 of this Agreement.

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

6

 

          (d) Severability. If any term, provision, covenant or restriction contained in the
Agreement is held by a court or a federal regulatory agency of competent jurisdiction to be
invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
contained in the Agreement shall remain in full force and effect, and shall in no way be affected,
impaired or invalidated.

          (e) Controlling Law. The Agreement is being made in Texas and shall be construed and
enforced in accordance with the laws of that state.

          (f) Construction. The Agreement and the Plan contain the entire understanding between
the parties, and supersedes any prior understanding and agreements between them, representing the
subject matter hereof. There are no representations, agreements, arrangements or understandings,
oral or written, between and among the parties hereto relating to the subject matter hereof which
are not fully expressed herein.

          (g) Amendments to Comply With Code §409A. Notwithstanding the foregoing, if any
provision of this Agreement would cause compensation to be includible in Employee’s income pursuant
to Code §409A(a)(1), then the Company may amend the Agreement in such a way as to cause
substantially similar economic results without causing such inclusion; any such amendment shall be
made by providing notice of such amendment to Employee, and shall be binding on Employee.

          (h) Headings. Section and other headings contained in the Agreement are for reference
purposes only and are in no way intended to describe, interpret, define or limit the scope, extent
or intent of the Agreement or any provision hereof.

     IN WITNESS WHEREOF, the parties hereto have executed the Agreement as of the day and year
first set forth above.

	 	 	 	 	 
	 	CASH AMERICA INTERNATIONAL, INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 
	 	EMPLOYEE

 	 
	 	 	 
	 	[____________] 	 
	 

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

7

 

EXHIBIT A

TERMS AND CONDITIONS OF PERFORMANCE AWARD

	1.	 	General. The amount of the Performance Award that will vest and be payable upon
vesting shall be based on the Company achieving growth in its [**Confidential Treatment
Requested] EPS over the three-year period ending December 31, 2011.
	 
	2.	 	Maximum Performance Award. 100% of the Performance Award shall vest and be payable if
the Company’s EPS achieves a [**Confidential Treatment
Requested] of [**Confidential Treatment Requested] when comparing the [**Confidential
Treatment Requested]  EPS for the year ended December 31, 2008 (see below), with the
EPS for the year ending December 31, 2011 (see below).
	 
	3.	 	Calculation of [**Confidential Treatment Requested]. The  [**Confidential
Treatment Requested] EPS shall be [**Confidential Treatment Requested]. The
[**Confidential Treatment Requested] shall reflect the [**Confidential Treatment Requested]
EPS over the three-year period ending December 31, 2011, [**Confidential Treatment Requested].
	 
	4.	 	Adjustments. If there is an increase or decrease in the number of issued and
outstanding shares of Common Stock through the payment of a stock dividend or resulting
from a stock split-up, a recapitalization or a combination or exchange of shares of Common
Stock, then the EPS [**Confidential Treatment Requested] used to calculate the amount of the Performance Award
shall be adjusted to reflect such increase or decrease.
	 
	5.	 	Vesting and Payment Amounts. The amount of the Performance Award that will vest and be
payable (subject to Committee Certification, as described below) shall be determined as
follows:

	 	a.	 	The Company’s  [**Confidential Treatment Requested] EPS must achieve a
[**Confidential Treatment Requested] of at least [**Confidential Treatment Requested]
in order for any amount of the Performance Award to vest and be payable; and with a
[**Confidential Treatment Requested] of [**Confidential Treatment Requested], the
amount of the Performance Award that will vest and be payable will be equal to
[**Confidential Treatment Requested] of the Performance Award (see the Performance
Schedule in Paragraph 7 below).
	 
	 	b.	 	100% of the Performance Award amount shall vest
and be payable if the Company’s [**Confidential Treatment Requested] EPS achieves a
[**Confidential Treatment Requested] of [**Confidential Treatment Requested] or more.
	 
	 	c.	 	If the Company’s [**Confidential Treatment Requested] EPS achieves a
[**Confidential Treatment Requested] of at least [**Confidential Treatment Requested]
but less than [**Confidential Treatment Requested], the amount of the Performance Award
that will vest and be payable shall increase in accordance with the Performance
Schedule in Paragraph 7 below. (See also the examples in Paragraph 8 below.)

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

 

 

	 	d.	 	No portion of the Performance Award will vest or be payable if the Company’s
[**Confidential Treatment Requested] EPS achieves a [**Confidential Treatment Requested] of
less than [**Confidential Treatment Requested].
	 
	 	e.	 	For purposes of determining the amount of the Performance Award that will vest
and be payable, [**Confidential Treatment Requested] shall be rounded to the nearest
[**Confidential Treatment Requested]; the calculated percentage of the amount of the
Performance Award payable at vesting will be rounded to the nearest 1.0%; and any
fractional share resulting from the calculation shall be rounded up to the next whole
share.

	6.	 	Committee Certification. At its first regularly scheduled meeting (or, if later, at
the first meeting held once the necessary EPS data has
become available) following the Performance Award Vesting Date (which meeting is
anticipated to occur during the last 14 days of January 14, 2012), the Management
Development and Compensation Committee (or any successor thereto) shall determine the
extent to which the conditions for the vesting of the Performance Award described in this
Appendix (the “Performance Goals”) have been met and shall certify the portion of
the Performance Award, if any, that has vested and is payable (“Committee
Certification”). Such Performance Goals will be considered to have been met only to
the extent that the Committee certifies in writing (within the meaning of Treasury
Regulations Section 1.162-27(e)(5)) that they have been met. The Committee Certification
shall include the satisfaction of the performance goals set forth in this Exhibit and of
the satisfaction of all other material terms of the Performance Award (including, without
limitation, the requirements of remaining continuously employed and/or attaining Rule of
65). The date the Committee makes such a written certification shall be deemed the
“Committee Certification Date”).
	 
	7.	 	Performance Schedule:

	 	 	 	 	 
	 	 	Percentage of
	 	 	Performance Award
	[**Confidential Treatment Requested]	 	to Be Issued**
	[**Confidential Treatment Requested]
	 	 	100	%
	[**Confidential Treatment Requested]
	 	 	99	%
	[**Confidential Treatment Requested]
	 	 	99	%
	[**Confidential Treatment Requested]
	 	 	98	%
	[**Confidential Treatment Requested]
	 	 	98	%
	[**Confidential Treatment Requested]
	 	 	97	%
	[**Confidential Treatment Requested]
	 	 	97	%
	[**Confidential Treatment Requested]
	 	 	96	%
	[**Confidential Treatment Requested]
	 	 	95	%
	[**Confidential Treatment Requested]
	 	 	95	%
	[**Confidential Treatment Requested]
	 	 	94	%
	[**Confidential Treatment Requested]
	 	 	94	%
	[**Confidential Treatment Requested]
	 	 	93	%
	[**Confidential Treatment Requested]
	 	 	93	%

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

 

 

	 	 	 	 	 
	 	 	Percentage of
	 	 	Performance Award
	[**Confidential Treatment Requested]	 	to Be Issued**
	[**Confidential Treatment Requested]
	 	 	92	%
	[**Confidential Treatment Requested]
	 	 	92	%
	[**Confidential Treatment Requested]
	 	 	91	%
	[**Confidential Treatment Requested]
	 	 	91	%
	[**Confidential Treatment Requested]
	 	 	90	%
	[**Confidential Treatment Requested]
	 	 	90	%
	[**Confidential Treatment Requested]
	 	 	89	%
	[**Confidential Treatment Requested]
	 	 	89	%
	[**Confidential Treatment Requested]
	 	 	88	%
	[**Confidential Treatment Requested]
	 	 	87	%
	[**Confidential Treatment Requested]
	 	 	87	%
	[**Confidential Treatment Requested]
	 	 	85	%
	[**Confidential Treatment Requested]
	 	 	83	%
	[**Confidential Treatment Requested]
	 	 	82	%
	[**Confidential Treatment Requested]
	 	 	80	%
	[**Confidential Treatment Requested]
	 	 	75	%
	[**Confidential Treatment Requested]
	 	 	71	%
	[**Confidential Treatment Requested]
	 	 	68	%
	[**Confidential Treatment Requested]
	 	 	64	%
	[**Confidential Treatment Requested]
	 	 	61	%
	[**Confidential Treatment Requested]
	 	 	57	%
	[**Confidential Treatment Requested]
	 	 	54	%
	[**Confidential Treatment Requested]
	 	 	50	%
	[**Confidential Treatment Requested]
	 	 	47	%
	[**Confidential Treatment Requested]
	 	 	43	%
	[**Confidential Treatment Requested]
	 	 	41	%
	[**Confidential Treatment Requested]
	 	 	38	%
	[**Confidential Treatment Requested]
	 	 	33	%
	[**Confidential Treatment Requested]
	 	 	30	%
	[**Confidential Treatment Requested]
	 	 	29	%
	[**Confidential Treatment Requested]
	 	 	27	%
	[**Confidential Treatment Requested]
	 	 	25	%
	[**Confidential Treatment Requested]
	 	 	23	%
	[**Confidential Treatment Requested]
	 	 	22	%
	[**Confidential Treatment Requested]
	 	 	0	%

 

			
	*	 	[**Confidential Treatment Requested] Percentage to be rounded to nearest [**Confidential Treatment Requested]
	 
	**	 	Percentage of Performance Award to Be Issued rounded to the nearest 1%

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

 

 

	8.	 	Examples: For purposes of these examples, assume Employee is granted a Performance
Award of 325 RSUs:

	 	a.	 	If the [**Confidential Treatment Requested] is [**Confidential Treatment
Requested], Employee shall receive the number of shares equal to 96% of the number of
RSUs granted as the Performance Award, rounded up to the next whole share or 312 shares
(325 * 96% = 312.0).
	 
	 	b.	 	If the [**Confidential Treatment Requested] is [**Confidential Treatment
Requested], Employee shall receive the number of shares equal to 47% of the number of
RSUs granted as the Performance Award rounded up to the next whole share or 153 shares
(325 * 47% = 152.75).
	 
	 	c.	 	If [**Confidential Treatment Requested] is [**Confidential Treatment
Requested], Employee shall receive the number of shares equal to 100% of the number of
RSUs granted as the Performance Award or 325 shares (325 * 100% = 325).
	 
	 	d.	 	If [**Confidential Treatment Requested] is [**Confidential Treatment
Requested], or less, Employee shall not receive any portion of the Performance Award.

“[**Confidential Treatment Requested]” denotes confidential materials omitted and filed separately
with the Securities and Exchange Commission pursuant to a request for confidential treatment.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00158-of-00352.parquet"}]]